Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Beeks wins 'significant' cloud deal with TMX

(Sharecast News) - AIM-listed Beeks Financial Cloud Group has announced a "significant" customer win with a new exchange cloud partnership with Canadian financial services group TMX. The agreement, with TMX's information services division TMX Datalinx, will see the latter offer Beeks' Exchange Cloud platform as TMX Elastic Market Access to its clients, subject to regulatory approval.

The infrastructure-as-a-service (IaaS) solution will give TMX Datalinx clients a "secure, low-latency and scalable hosting solution tailored for high-performance trading and data analytics, opening up the solution to TMX Datalinx's large base of financial services customers in Canada and globally", Beeks said in a statement.

The partnership is a revenue share deal, expected to start in early 2026.

"TMX Datalinx's adoption of our solution is a strong endorsement of our ability to meet the unique demands of global financial exchanges," said chief executive Gordon McArthur.

"It reflects the growing market appetite for flexible, cloud-based trading infrastructure, opening up new possibilities for how capital markets participants build and deploy trading systems."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.